GENZYME CORP Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 26 rows in 2006. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2006-08-31: Reporting owner SMITH SANDFORD D; Form 4; Security Genzyme ISO stock option (right to buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2006-08-31: Reporting owner SMITH SANDFORD D; Form 4; Security Genzyme NQ stock option (right to buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2006-07-27: Reporting owner COONEY CHARLES L; Form 4; Security Genzyme DOP stock option (right to buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2006-05-30: Reporting owner GEMAYEL GEORGES; Form 4; Security Genzyme ISO stock option (right to buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2006-08-31 | SMITH SANDFORD D Officer (Executive Vice President) | 4 | Genzyme ISO stock option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,075 0 owned after | $32.52 exercise price | 2006-09-05 | |
| 2006-08-31 | SMITH SANDFORD D Officer (Executive Vice President) | 4 | Genzyme NQ stock option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −11,145 0 owned after | $32.52 exercise price | 2006-09-05 | |
| 2006-07-27 | COONEY CHARLES L Director | 4 | Genzyme DOP stock option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −16,000 0 owned after | $20.59 exercise price | 2006-07-31 | |
| 2006-05-30 | GEMAYEL GEORGES Officer (Executive Vice President) | 4 | Genzyme ISO stock option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −2,277 4,554 owned after | $43.90 exercise price | 2006-06-01 | |
| 2006-05-25 | WYZGA MICHAEL S Officer (Executive VP and CFO) | 4 | Genzyme NQ Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +69,000 69,000 owned after | $58.50 exercise price | 2006-05-30 | |
| 2006-05-25 | WIRTH PETER Officer (Executive Vice President) | 4 | Genzyme NQ Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +69,000 69,000 owned after | $58.50 exercise price | 2006-05-30 | |
| 2006-05-25 | SMITH SANDFORD D Officer (Senior Vice President) | 4 | Genzyme NQ Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +69,000 69,000 owned after | $58.50 exercise price | 2006-05-30 | |
| 2006-05-25 | SMITH ALAN E Officer (Senior Vice President) | 4 | Genzyme NQ Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +48,500 48,500 owned after | $58.50 exercise price | 2006-05-30 | |
| 2006-05-25 | MOSCICKI RICHARD A Officer (Senior Vice President) | 4 | Genzyme NQ Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +48,500 48,500 owned after | $58.50 exercise price | 2006-05-30 | |
| 2006-05-25 | GEMAYEL GEORGES Officer (Executive Vice President) | 4 | Genzyme NQ Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +69,000 69,000 owned after | $58.50 exercise price | 2006-05-30 | |
| 2006-05-25 | CSIMMA ZOLTAN A Officer (Senior VP, Human Resources) | 4 | Genzyme NQ Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +35,000 35,000 owned after | $58.50 exercise price | 2006-05-30 | |
| 2006-05-25 | COLLIER EARL M JR Officer (Executive Vice President) | 4 | Genzyme NQ Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +69,000 69,000 owned after | $58.50 exercise price | 2006-05-30 | |
| 2006-05-25 | SYRON RICHARD F/CA Director | 4 | Genzyme DOP NQ Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +15,000 15,000 owned after | $58.50 exercise price | 2006-05-26 | |
| 2006-05-25 | MCGILLICUDY CORNELIUS III Director | 4 | Genzyme DOP NQ Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +15,000 15,000 owned after | $58.50 exercise price | 2006-05-26 | |
| 2006-05-25 | DZAU VICTOR J Director | 4 | Genzyme DOP NQ Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +15,000 15,000 owned after | $58.50 exercise price | 2006-05-26 | |
| 2006-05-25 | COONEY CHARLES L Director | 4 | Genzyme DOP NQ Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +15,000 15,000 owned after | $58.50 exercise price | 2006-05-26 | |
| 2006-05-25 | CARPENTER ROBERT J Director | 4 | Genzyme DOP NQ Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +15,000 15,000 owned after | $58.50 exercise price | 2006-05-26 | |
| 2006-05-25 | TERMEER HENRI A Director, Officer (Chmn, President and CEO) | 4 | Genzyme NQ Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +400,000 400,000 owned after | $58.50 exercise price | 2006-05-26 | |
| 2006-05-25 | BOUDREAUX GAIL Director | 4 | Genzyme DOP NQ Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +15,000 15,000 owned after | $58.50 exercise price | 2006-05-26 | |
| 2006-05-25 | BLAIR HENRY E Director | 4 | Genzyme DOP NQ Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +15,000 15,000 owned after | $58.50 exercise price | 2006-05-26 | |
| 2006-05-25 | BERTHIAUME DOUGLAS A Director | 4 | Genzyme DOP NQ Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +15,000 15,000 owned after | $58.50 exercise price | 2006-05-26 | |
| 2006-03-01 | SYRON RICHARD F/CA Director | 4 | Genzyme NQ stock option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +15,000 15,000 owned after | $68.69 exercise price | 2006-03-10 | |
| 2006-03-01 | SMITH SANDFORD D Officer (Senior Vice President) | 4 | Genzyme NQ stock option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −12,500 44,500 owned after | $43.90 exercise price | 2006-03-03 | |
| 2006-02-28 | SYRON RICHARD F/CA Director | 4/A | Genzyme DOP stock option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +15,000 15,000 owned after | $69.34 exercise price | 2006-04-21 | |
| 2006-01-04 | MOSCICKI RICHARD A Officer (Senior Vice President) | 4/A | Genzyme ISO stock option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −21,344 0 owned after | $15.13 exercise price | 2006-01-19 | |
| 2006-01-04 | MOSCICKI RICHARD A Officer (Senior Vice President) | 4 | Genzyme ISO stock option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −21,344 0 owned after | $15.13 exercise price | 2006-01-05 |